- call +1-201-465-4211
- email sales@mrinsights.biz
According to this latest study, the 2021 growth of Favipiravir will have significant change from previous year. By the most conservative estimates of global Favipiravir market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Favipiravir market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Favipiravir market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Original Drug
Generic Drug
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Influenza Viruses
HIV
SARS
Ebola
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Fujifilm Toyama Chemical
CSPC Pharmaceutical Group
Reyoung Pharmaceutical
Sihuan Pharmaceutical
Hisun Pharm
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Favipiravir Consumption 2016-2026
2.1.2 Favipiravir Consumption CAGR by Region
2.2 Favipiravir Segment by Type
2.2.1 Original Drug
2.2.2 Generic Drug
2.3 Favipiravir Sales by Type
2.3.1 Global Favipiravir Sales Market Share by Type (2016-2021)
2.3.2 Global Favipiravir Revenue and Market Share by Type (2016-2021)
2.3.3 Global Favipiravir Sale Price by Type (2016-2021)
2.4 Favipiravir Segment by Application
2.4.1 Influenza Viruses
2.4.2 HIV
2.4.3 SARS
2.4.4 Ebola
2.4.5 Other
2.5 Favipiravir Sales by Application
2.5.1 Global Favipiravir Sale Market Share by Application (2016-2021)
2.5.2 Global Favipiravir Revenue and Market Share by Application (2016-2021)
2.5.3 Global Favipiravir Sale Price by Application (2016-2021)
3 Global Favipiravir by Company
3.1 Global Favipiravir Sales Market Share by Company
3.1.1 Global Favipiravir Sales by Company (2019-2021)
3.1.2 Global Favipiravir Sales Market Share by Company (2019-2021)
3.2 Global Favipiravir Revenue Market Share by Company
3.2.1 Global Favipiravir Revenue by Company (2019-2021)
3.2.2 Global Favipiravir Revenue Market Share by Company (2019-2021)
3.3 Global Favipiravir Sale Price by Company
3.4 Global Manufacturers Favipiravir Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Favipiravir Product Location Distribution
3.4.2 Players Favipiravir Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Favipiravir by Region
4.1 Global Favipiravir by Region
4.1.1 Global Favipiravir Sales by Region
4.1.2 Global Favipiravir Revenue by Region
4.2 Americas Favipiravir Sales Growth
4.3 APAC Favipiravir Sales Growth
4.4 Europe Favipiravir Sales Growth
4.5 Middle East & Africa Favipiravir Sales Growth
5 Americas
5.1 Americas Favipiravir Sales by Country
5.1.1 Americas Favipiravir Sales by Country (2016-2021)
5.1.2 Americas Favipiravir Revenue by Country (2016-2021)
5.2 Americas Favipiravir Sales by Type
5.3 Americas Favipiravir Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Favipiravir Sales by Region
6.1.1 APAC Favipiravir Sales by Region (2016-2021)
6.1.2 APAC Favipiravir Revenue by Region (2016-2021)
6.2 APAC Favipiravir Sales by Type
6.3 APAC Favipiravir Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Favipiravir by Country
7.1.1 Europe Favipiravir Sales by Country (2016-2021)
7.1.2 Europe Favipiravir Revenue by Country (2016-2021)
7.2 Europe Favipiravir Sales by Type
7.3 Europe Favipiravir Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Favipiravir by Country
8.1.1 Middle East & Africa Favipiravir Sales by Country (2016-2021)
8.1.2 Middle East & Africa Favipiravir Revenue by Country (2016-2021)
8.2 Middle East & Africa Favipiravir Sales by Type
8.3 Middle East & Africa Favipiravir Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Favipiravir Distributors
10.3 Favipiravir Customer
11 Global Favipiravir Market Forecast
11.1 Global Favipiravir Forecast by Region
11.1.1 Global Favipiravir Forecast by Regions (2021-2026)
11.2.2 Global Favipiravir Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Favipiravir Forecast by Type
11.7 Global Favipiravir Forecast by Application
12 Key Players Analysis
12.1 Fujifilm Toyama Chemical
12.1.1 Fujifilm Toyama Chemical Company Information
12.1.2 Fujifilm Toyama Chemical Favipiravir Product Offered
12.1.3 Fujifilm Toyama Chemical Favipiravir Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Fujifilm Toyama Chemical Main Business Overview
12.1.5 Fujifilm Toyama Chemical Latest Developments
12.2 CSPC Pharmaceutical Group
12.2.1 CSPC Pharmaceutical Group Company Information
12.2.2 CSPC Pharmaceutical Group Favipiravir Product Offered
12.2.3 CSPC Pharmaceutical Group Favipiravir Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 CSPC Pharmaceutical Group Main Business Overview
12.2.5 CSPC Pharmaceutical Group Latest Developments
12.3 Reyoung Pharmaceutical
12.3.1 Reyoung Pharmaceutical Company Information
12.3.2 Reyoung Pharmaceutical Favipiravir Product Offered
12.3.3 Reyoung Pharmaceutical Favipiravir Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Reyoung Pharmaceutical Main Business Overview
12.3.5 Reyoung Pharmaceutical Latest Developments
12.4 Sihuan Pharmaceutical
12.4.1 Sihuan Pharmaceutical Company Information
12.4.2 Sihuan Pharmaceutical Favipiravir Product Offered
12.4.3 Sihuan Pharmaceutical Favipiravir Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Sihuan Pharmaceutical Main Business Overview
12.4.5 Sihuan Pharmaceutical Latest Developments
12.5 Hisun Pharm
12.5.1 Hisun Pharm Company Information
12.5.2 Hisun Pharm Favipiravir Product Offered
12.5.3 Hisun Pharm Favipiravir Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Hisun Pharm Main Business Overview
12.5.5 Hisun Pharm Latest Developments
...
13 Research Findings and Conclusion
List of Tables
Table 1. Favipiravir Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Original Drug
Table 3. Major Players of Generic Drug
Table 4. Global Favipiravir Sales by Type (2016-2021) & (K Units)
Table 5. Global Favipiravir Sales Market Share by Type (2016-2021)
Table 6. Global Favipiravir Revenue by Type (2016-2021) & ($ million)
Table 7. Global Favipiravir Revenue Market Share by Type (2016-2021)
Table 8. Global Favipiravir Sale Price by Type (2016-2021)
Table 9. Global Favipiravir Sales by Application (2016-2021) & (K Units)
Table 10. Global Favipiravir Sales Market Share by Application (2016-2021)
Table 11. Global Favipiravir Value by Application (2016-2021)
Table 12. Global Favipiravir Revenue Market Share by Application (2016-2021)
Table 13. Global Favipiravir Sale Price by Application (2016-2021)
Table 14. Global Favipiravir Sales by Company (2019-2021) & (K Units)
Table 15. Global Favipiravir Sales Market Share by Company (2019-2021)
Table 16. Global Favipiravir Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Favipiravir Revenue Market Share by Company (2019-2021)
Table 18. Global Favipiravir Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Favipiravir Producing Area Distribution and Sales Area
Table 20. Players Favipiravir Products Offered
Table 21. Favipiravir Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Favipiravir Sales by Region (2016-2021) (K Units)
Table 25. Global Favipiravir Sales Market Share by Region (2016-2021)
Table 26. Global Favipiravir Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Favipiravir Revenue Market Share by Region (2016-2021)
Table 28. Americas Favipiravir Sales by Country (2016-2021) & (K Units)
Table 29. Americas Favipiravir Sales Market Share by Country (2016-2021)
Table 30. Americas Favipiravir Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Favipiravir Revenue Market Share by Country (2016-2021)
Table 32. Americas Favipiravir Sales by Type (2016-2021) & (K Units)
Table 33. Americas Favipiravir Sales Market Share by Type (2016-2021)
Table 34. Americas Favipiravir Sales by Application (2016-2021) & (K Units)
Table 35. Americas Favipiravir Sales Market Share by Application (2016-2021)
Table 36. APAC Favipiravir Sales by Region (2016-2021) & (K Units)
Table 37. APAC Favipiravir Sales Market Share by Region (2016-2021)
Table 38. APAC Favipiravir Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Favipiravir Revenue Market Share by Region (2016-2021)
Table 40. APAC Favipiravir Sales by Type (2016-2021) & (K Units)
Table 41. APAC Favipiravir Sales Market Share by Type (2016-2021)
Table 42. APAC Favipiravir Sales by Application (2016-2021) & (K Units)
Table 43. APAC Favipiravir Sales Market Share by Application (2016-2021)
Table 44. Europe Favipiravir Sales by Country (2016-2021) & (K Units)
Table 45. Europe Favipiravir Sales Market Share by Country (2016-2021)
Table 46. Europe Favipiravir Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Favipiravir Revenue Market Share by Country (2016-2021)
Table 48. Europe Favipiravir Sales by Type (2016-2021) & (K Units)
Table 49. Europe Favipiravir Sales Market Share by Type (2016-2021)
Table 50. Europe Favipiravir Sales by Application (2016-2021) & (K Units)
Table 51. Europe Favipiravir Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Favipiravir Sales by Country (2016-2021) & (K Units)
Table 53. Middle East & Africa Favipiravir Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Favipiravir Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Favipiravir Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Favipiravir Sales by Type (2016-2021) & (K Units)
Table 57. Middle East & Africa Favipiravir Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Favipiravir Sales by Application (2016-2021) & (K Units)
Table 59. Middle East & Africa Favipiravir Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Favipiravir
Table 61. Key Application and Potential Industries of Favipiravir
Table 62. Key Challenges of Favipiravir
Table 63. Key Trends of Favipiravir
Table 64. Favipiravir Distributors List
Table 65. Favipiravir Customer List
Table 66. Global Favipiravir Sales Forecast by Region (2021-2026) & (K Units)
Table 67. Global Favipiravir Consumption Market Forecast by Region
Table 68. Global Favipiravir Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Favipiravir Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Favipiravir Sales Forecast by Country (2021-2026) & (K Units)
Table 71. Americas Favipiravir Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Favipiravir Sales Forecast by Region (2021-2026) & (K Units)
Table 73. APAC Favipiravir Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Favipiravir Sales Forecast by Country (2021-2026) & (K Units)
Table 75. Europe Favipiravir Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Favipiravir Sales Forecast by Country (2021-2026) & (K Units)
Table 77. Middle East & Africa Favipiravir Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Favipiravir Sales Forecast by Type (2021-2026) & (K Units)
Table 79. Global Favipiravir Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Favipiravir Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Favipiravir Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Favipiravir Sales Forecast by Application (2021-2026) & (K Units)
Table 83. Global Favipiravir Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Favipiravir Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Favipiravir Revenue Market Share Forecast by Application (2021-2026)
Table 86. Fujifilm Toyama Chemical Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 87. Fujifilm Toyama Chemical Favipiravir Product Offered
Table 88. Fujifilm Toyama Chemical Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 89. Fujifilm Toyama Chemical Main Business
Table 90. Fujifilm Toyama Chemical Latest Developments
Table 91. CSPC Pharmaceutical Group Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 92. CSPC Pharmaceutical Group Favipiravir Product Offered
Table 93. CSPC Pharmaceutical Group Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 94. CSPC Pharmaceutical Group Main Business
Table 95. CSPC Pharmaceutical Group Latest Developments
Table 96. Reyoung Pharmaceutical Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 97. Reyoung Pharmaceutical Favipiravir Product Offered
Table 98. Reyoung Pharmaceutical Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 99. Reyoung Pharmaceutical Main Business
Table 100. Reyoung Pharmaceutical Latest Developments
Table 101. Sihuan Pharmaceutical Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 102. Sihuan Pharmaceutical Favipiravir Product Offered
Table 103. Sihuan Pharmaceutical Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 104. Sihuan Pharmaceutical Main Business
Table 105. Sihuan Pharmaceutical Latest Developments
Table 106. Hisun Pharm Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 107. Hisun Pharm Favipiravir Product Offered
Table 108. Hisun Pharm Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 109. Hisun Pharm Main Business
Table 110. Hisun Pharm Latest Developments
List of Figures
Figure 1. Picture of Favipiravir
Figure 2. Favipiravir Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Favipiravir Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Favipiravir Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Favipiravir Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Original Drug
Figure 10. Product Picture of Generic Drug
Figure 11. Global Favipiravir Sales Market Share by Type in 2020
Figure 12. Global Favipiravir Revenue Market Share by Type (2016-2021)
Figure 13. Favipiravir Consumed in Influenza Viruses
Figure 14. Global Favipiravir Market: Influenza Viruses (2016-2021) & (K Units)
Figure 15. Favipiravir Consumed in HIV
Figure 16. Global Favipiravir Market: HIV (2016-2021) & (K Units)
Figure 17. Favipiravir Consumed in SARS
Figure 18. Global Favipiravir Market: SARS (2016-2021) & (K Units)
Figure 19. Favipiravir Consumed in Ebola
Figure 20. Global Favipiravir Market: Ebola (2016-2021) & (K Units)
Figure 21. Favipiravir Consumed in Other
Figure 22. Global Favipiravir Market: Other (2016-2021) & (K Units)
Figure 23. Global Favipiravir Sales Market Share by Application (2016-2021)
Figure 24. Global Favipiravir Revenue Market Share by Application in 2020
Figure 25. Favipiravir Revenue Market by Company in 2020 ($ Million)
Figure 26. Global Favipiravir Revenue Market Share by Company in 2020
Figure 27. Global Favipiravir Sales Market Share by Regions (2016-2021)
Figure 28. Global Favipiravir Revenue Market Share by Region in 2020
Figure 29. Americas Favipiravir Sales 2016-2021 (K Units)
Figure 30. Americas Favipiravir Revenue 2016-2021 ($ Millions)
Figure 31. APAC Favipiravir Sales 2016-2021 (K Units)
Figure 32. APAC Favipiravir Revenue 2016-2021 ($ Millions)
Figure 33. Europe Favipiravir Sales 2016-2021 (K Units)
Figure 34. Europe Favipiravir Revenue 2016-2021 ($ Millions)
Figure 35. Middle East & Africa Favipiravir Sales 2016-2021 (K Units)
Figure 36. Middle East & Africa Favipiravir Revenue 2016-2021 ($ Millions)
Figure 37. Americas Favipiravir Sales Market Share by Country in 2020
Figure 38. Americas Favipiravir Revenue Market Share by Country in 2020
Figure 39. Americas Favipiravir Sales Market Share by Type in 2020
Figure 40. Americas Favipiravir Sales Market Share by Application in 2020
Figure 41. United States Favipiravir Revenue Growth 2016-2021 ($ Millions)
Figure 42. Canada Favipiravir Revenue Growth 2016-2021 ($ Millions)
Figure 43. Mexico Favipiravir Revenue Growth 2016-2021 ($ Millions)
Figure 44. Brazil Favipiravir Revenue Growth 2016-2021 ($ Millions)
Figure 45. APAC Favipiravir Sales Market Share by Region in 2020
Figure 46. APAC Favipiravir Revenue Market Share by Regions in 2020
Figure 47. APAC Favipiravir Sales Market Share by Type in 2020
Figure 48. APAC Favipiravir Sales Market Share by Application in 2020
Figure 49. China Favipiravir Revenue Growth 2016-2021 ($ Millions)
Figure 50. Japan Favipiravir Revenue Growth 2016-2021 ($ Millions)
Figure 51. Korea Favipiravir Revenue Growth 2016-2021 ($ Millions)
Figure 52. Southeast Asia Favipiravir Revenue Growth 2016-2021 ($ Millions)
Figure 53. India Favipiravir Revenue Growth 2016-2021 ($ Millions)
Figure 54. Australia Favipiravir Revenue Growth 2016-2021 ($ Millions)
Figure 55. Europe Favipiravir Sales Market Share by Country in 2020
Figure 56. Europe Favipiravir Revenue Market Share by Country in 2020
Figure 57. Europe Favipiravir Sales Market Share by Type in 2020
Figure 58. Europe Favipiravir Sales Market Share by Application in 2020
Figure 59. Germany Favipiravir Revenue Growth 2016-2021 ($ Millions)
Figure 60. France Favipiravir Revenue Growth 2016-2021 ($ Millions)
Figure 61. UK Favipiravir Revenue Growth 2016-2021 ($ Millions)
Figure 62. Italy Favipiravir Revenue Growth 2016-2021 ($ Millions)
Figure 63. Russia Favipiravir Revenue Growth 2016-2021 ($ Millions)
Figure 64. Middle East & Africa Favipiravir Sales Market Share by Country in 2020
Figure 65. Middle East & Africa Favipiravir Revenue Market Share by Country in 2020
Figure 66. Middle East & Africa Favipiravir Sales Market Share by Type in 2020
Figure 67. Middle East & Africa Favipiravir Sales Market Share by Application in 2020
Figure 68. Egypt Favipiravir Revenue Growth 2016-2021 ($ Millions)
Figure 69. South Africa Favipiravir Revenue Growth 2016-2021 ($ Millions)
Figure 70. Israel Favipiravir Revenue Growth 2016-2021 ($ Millions)
Figure 71. Turkey Favipiravir Revenue Growth 2016-2021 ($ Millions)
Figure 72. GCC Country Favipiravir Revenue Growth 2016-2021 ($ Millions)
Figure 73. Channels of Distribution
Figure 74. Distributors Profiles
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
